Linneo Health
Don Bellamy is an accomplished executive with extensive experience in the pharmaceutical and medical cannabis industries. Currently serving as Chief Executive Officer at Linneo Health since February 2021, Bellamy leads the company in producing EU-GMP and GACP certified medical cannabis. Prior to this role, Bellamy founded Goodfriend Consulting, providing expert consulting services in life sciences. Notable previous positions include Senior Vice President of Global Medical Products at Canopy Growth Corporation, Global Head of Marketing & Launch Excellence at Baxalta, and various leadership roles at Novartis, where responsibilities spanned commercial strategy and operational excellence across multiple regions. Bellamy's educational background includes a MA Hons in Economics from the University of St Andrews and an Associate's degree from The Chartered Institute of Marketing.
This person is not in any teams
This person is not in any offices
Linneo Health
1 followers
Linneo Health is a Europe based global leader in the research, cultivation and supply of cannabis to improve human health and wellbeing. As the world’s only vertically integrated medicinal cannabis supplier, no other company has our 90-year heritage in the manufacturing and movement of controlled substances. We are optimally positioned to address the needs of our customers through every stage of product development, regulation and handling. We are setting the benchmark for standards and customer service in medicinal cannabis. Through ongoing investment in one of the most advanced quality control laboratories in Europe, and by applying industry-leading cultivation techniques, we are the trusted partner to address the needs of customers today and, with significant expansion capabilities, the demands of tomorrow. With an unrivalled focus on quality and driven by the firm belief that people around the world deserve to be treated with cannabis medicine of the highest standard, we bring cutting edge innovation in medicinal cannabis to partners, to deliver better patient outcomes and improve lives.